Skip to main content

Peer Review reports

From: S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial

Original Submission
27 May 2014 Submitted Original manuscript
7 Jun 2014 Author responded Author comments - Young Park
Resubmission - Version 2
7 Jun 2014 Submitted Manuscript version 2
9 Jul 2014 Reviewed Reviewer Report - Young-Woong Won
11 Jul 2014 Reviewed Reviewer Report - Jung Hun kang
Resubmission - Version 3
Submitted Manuscript version 3
20 Aug 2014 Author responded Author comments - Young Park
Resubmission - Version 4
20 Aug 2014 Submitted Manuscript version 4
27 Sep 2014 Reviewed Reviewer Report - Jung Hun kang
11 Oct 2014 Author responded Author comments - Young Park
Resubmission - Version 5
11 Oct 2014 Submitted Manuscript version 5
23 Oct 2014 Author responded Author comments - Young Park
Resubmission - Version 6
23 Oct 2014 Submitted Manuscript version 6
29 Oct 2014 Author responded Author comments - Young Park
Resubmission - Version 7
29 Oct 2014 Submitted Manuscript version 7
10 Nov 2014 Author responded Author comments - Young Park
Resubmission - Version 8
10 Nov 2014 Submitted Manuscript version 8
Publishing
18 Nov 2014 Editorially accepted
26 Nov 2014 Article published 10.1186/1471-2407-14-883

You can find further information about peer review here.

Back to article page